MWM
PBE icon

MinichMacGregor Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

MinichMacGregor Wealth Management’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$372K Buy
+3,819
New +$358K 0.06% 100

Other funds holding PBE

YIA
YHB Investment Advisors West Hartford, Connecticut $1.59B AUM 21.04% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.52B AUM 15.33% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
AMBIA
Allen Mooney & Barnes Investment Advisors Thomasville, Georgia $673M AUM 20.03% 1-Year Est. Return
FPB
First PREMIER Bank Sioux Falls, South Dakota $621M AUM 13.03% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return
RIA
Realta Investment Advisors Wilmington, Delaware $342M AUM 30.02% 1-Year Est. Return

MinichMacGregor Wealth Management's PBE Position: Q3 2026 in Review

MinichMacGregor Wealth Management opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q3 2026: 3,819 shares worth $372K. The stake represents 0.06% of the portfolio and ranks #100 among its holdings.

12 funds tracked by Wall St. Rank hold PBE as of Q3 2026.

  • MinichMacGregor Wealth Management held 3,819 shares of Invesco Biotechnology & Genome ETF worth $372K as of Q3 2026.
  • Invesco Biotechnology & Genome ETF was a new MinichMacGregor Wealth Management position in Q3 2026.
  • Invesco Biotechnology & Genome ETF made up 0.06% of MinichMacGregor Wealth Management's portfolio in Q3 2026, its #100 holding.
  • 12 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.

Based on MinichMacGregor Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.